Thinkhamrop K, Khuntikeo N, Sithithaworn P, Thinkhamrop W, Wangdi K, Kelly MJ, Suwannatrai AT, Gray DJ
This peptide also demonstrates anti-inflammatory effects, reducing swelling and pain associated with injuries
Many of the neuroprotective, neurodegenerative, psychiatric, and addiction-related applications discussed remain investigational, and no GLP-1 receptor agonist is currently approved by regulatory authorities for the treatment or prevention of Alzheimers disease, Parkinsons disease, depression, substance use disorders, or other neurological indications unless specifically stated otherwise
Public Health Implications Population-level interventions may be needed to address environmental factors that promote widespread motivational dysfunction
7-HMR also lowered the levels of proinflammatory mediators: brain tissue analyses revealed decreases in TNF- and iNOS (inducible nitric oxide synthase) with 7-HMR therapy (62)